News & Publications

Women's Health

The 1 Birth Control Pill Risk You Should Know About Above All Else

Headlines in Reproductive Medicine August 27, 2015

The Internet is flooded with information about contraception these days, and you have probably heard your fair share about IUDs and diaphragms and any other form of birth control that is available through your insurance provider. As you're wading through the muck of statistics, though, there are a few things you need to pay attention to more than others. If you're either currently taking the birth control pill or you're shopping around for new contraception, listen carefully — because the most significant risk you face when you choose the Pill is developing blood clots.

The History of Birth Control: How We’ve Been Trying To Prevent Babies Since The Beginning of Time

Headlines in Reproductive Medicine August 24, 2015

Birth control: two words that hold plenty of controversy, heated emotions, and in many cases, consequences that can change one’s life. In the modern world, contraception has somehow garnered a bad reputation, considered by some an unnatural way to toy with pregnancy and bearing children — particularly among certain religious groups.

Pregnancy Intentions Don't Influence Women's Birth Control Choices As Much As Relationships, Sexual Activity

Headlines in Reproductive Medicine August 24, 2015

As of now, the Centers for Disease Control and Prevention (CDC) estimates that 62 percent of women who are of reproductive age use contraception, the most popular choice being oral contraceptives, which 28 percent of women use. While oral contraception may be more common among women than ever before, the reason why may not be what you think. According to a new study published in the journal Contraception, women have made their contraception choice based on current relationships and sexual activity, not their long-term pregnancy goals.

Here's What Sexperts Think About Female Viagra and Why You Shouldn't Call It That

Headlines in Reproductive Medicine August 24, 2015

When news broke on August 18 that the Food and Drug Administration approved Addyi, the pill that is being incorrectly referred to as the "female Viagra," it might have seemed like an obvious feminist win. Viagra has been around since 1998, but there hasn't been anything remotely comparable on the market for women. Addyi is supposed to alleviate female hypoactive sexual desire disorder (or lack of sexual desire). But as we've reported, women on Addyi experienced an increase of only one sexual event per month during clinical trials.

Maker of Addyi, ‘Female Viagra’ Drug, Being Sold to Valeant for $1 Billion

Headlines in Reproductive Medicine August 24, 2015

Sprout Pharmaceuticals, which on Tuesday won regulatory approval for the first pill to aid a woman’s sex drive, will be acquired by Valeant Pharmaceuticals International for about $1 billion in cash.

ACOG Updates Emergency Contraception Guidelines

Headlines in Reproductive Medicine August 20, 2015

The American College of Obstetricians and Gynecologists (ACOG) published a Practice Bulletin concerning emergency contraception online August 19 and in the September issue of Obstetrics & Gynecology. The new recommendations, which update those published by ACOG in May 2010, include an expanded discussion and guidance on the use of ulipristal acetate and new data regarding the effect of body weight on emergency contraception efficacy.

Infertility Treatments not Associated with Increased Short-term Cancer Risk

Headlines in Reproductive Medicine August 17, 2015

Compared to the general population, women who underwent assisted reproductive technologies (ART) treatments were not at increased risk for developing cancer after approximately 5 years of follow-up.

Study Says Quitting Smoking Can Reduce Hot Flashes in Menopausal Women

Headlines in Reproductive Medicine August 17, 2015

Health researchers have recently discerned that women of a particular age who choose to give up smoking can actually get the added benefit of experience fewer hot flashes if they succeed.

Comments from ASRM and SART on “Outcomes of Fresh and Cryopreserved Oocyte Donation”

Press Releases August 11, 2015

James Toner, MD, SART President remarked, “We appreciate Dr. Kushnir and his colleagues’ sharing their analysis comparing the outcomes of cycles using frozen donor eggs with outcomes of fresh donor egg cycles. This year, for the first time, SART included frozen donor egg cycles in its National Report, enabling this large-scale, nationwide comparison to be done. 

FDA’s Obstetrics and Gynecology Devices Panel Will Meet on September 24, 2015 to Discuss the Essure System

ASRM Bulletins July 29, 2015

The OB/Gyn Devices Panel of FDA’s Medical Devices Advisory Committee is convening to seek expert scientific and clinical input on the risks and benefits of Bayer HealthCare’s Essure System for permanent female sterilization.


View Details
Learn More | Join | Renew
Back to Top